65,000 DENTSPLY SIRONA Inc. $XRAY Shares Bought by Edmond DE Rothschild Holding S.A.

Edmond DE Rothschild Holding S.A. boosted its holdings in DENTSPLY SIRONA Inc. (NASDAQ:XRAY – Free Report) by 1.4% during the 3rd quarter, HoldingsChannel.com reports. The institutional investor owned 4,568,300 shares of the medical instruments supplier’s stock after purchasing an additional 65,000 shares during the quarter. Edmond DE Rothschild Holding S.A.’s holdings in DENTSPLY SIRONA were worth $40,475,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. BlackRock Inc. acquired a new position in DENTSPLY SIRONA in the second quarter valued at $283,405,000. Southpoint Capital Advisors LP acquired a new stake in DENTSPLY SIRONA during the 1st quarter worth approximately $116,000,000. Paradigm Capital Management Inc. NY purchased a new position in shares of DENTSPLY SIRONA in the 2nd quarter valued at approximately $39,775,000. Dimensional Fund Advisors LP grew its stake in shares of DENTSPLY SIRONA by 31.4% in the 1st quarter. Dimensional Fund Advisors LP now owns 3,559,388 shares of the medical instruments supplier’s stock valued at $41,284,000 after purchasing an additional 850,261 shares during the last quarter. Finally, Private Management Group Inc. grew its stake in shares of DENTSPLY SIRONA by 18.9% in the 3rd quarter. Private Management Group Inc. now owns 2,936,998 shares of the medical instruments supplier’s stock valued at $26,022,000 after purchasing an additional 466,272 shares during the last quarter. Institutional investors and hedge funds own 95.70% of the company’s stock.

Analyst Ratings Changes

Several equities research analysts have recently commented on XRAY shares. Barclays upped their price target on DENTSPLY SIRONA from $9.00 to $11.00 and gave the stock an “underweight” rating in a research note on Monday, August 24th. BMO Capital Markets dropped their price objective on shares of DENTSPLY SIRONA from $13.00 to $10.00 and set a “market perform” rating on the stock in a research note on Thursday, September 17th. UBS Group dropped their price objective on shares of DENTSPLY SIRONA from $17.00 to $13.00 and set a “buy” rating on the stock in a research note on Monday. Piper Sandler cut their price objective on shares of DENTSPLY SIRONA from $14.00 to $12.00 and set a “neutral” rating for the company in a research report on Friday, October 9th. Finally, Mizuho reduced their target price on shares of DENTSPLY SIRONA from $14.00 to $12.00 and set a “neutral” rating for the company in a research note on Thursday, October 22nd. Three investment analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and four have given a Sell rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Reduce” and a consensus price target of $12.08.

Get Our Latest Report on DENTSPLY SIRONA

DENTSPLY SIRONA Trading Down 0.4%

Shares of XRAY opened at $8.49 on Friday. The company has a current ratio of 1.63, a quick ratio of 1.04 and a debt-to-equity ratio of 1.47. The firm’s 50-day moving average is $9.25 and its two-hundred day moving average is $11.12. DENTSPLY SIRONA Inc. has a twelve month low of $8.14 and a twelve month high of $14.76. The firm has a market capitalization of $1.68 billion, a P/E ratio of -13.69, a PEG ratio of 1.25 and a beta of 0.87.

DENTSPLY SIRONA (NASDAQ:XRAY – Get Free Report) last issued its earnings results on Thursday, November 5th. The medical instruments supplier reported $0.29 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.31 by ($0.02). DENTSPLY SIRONA had a negative net margin of 3.38% and a positive return on equity of 20.21%. The company had revenue of $836.00 million during the quarter, compared to analysts’ expectations of $861.68 million. During the same period last year, the business posted $0.37 earnings per share. The company’s quarterly revenue was down 7.5% on a year-over-year basis. DENTSPLY SIRONA has set its FY 2026 guidance at 1.200-1.300 EPS. On average, research analysts predict that DENTSPLY SIRONA Inc. will post 1.21 earnings per share for the current fiscal year.

About DENTSPLY SIRONA

(Free Report)

DENTSPLY SIRONA Inc. develops, manufactures and markets products and technologies for dental professionals. Its portfolio includes dental equipment and imaging systems, digital dentistry and CAD/CAM solutions, dental implants, endodontic and restorative products, and supplies used in preventive care. The company serves dental practices, laboratories and other customers around the world. Its products support a range of clinical activities, including diagnosis, treatment planning, restorative dentistry and oral hygiene.

Featured Stories

Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DENTSPLY SIRONA Inc. (NASDAQ:XRAY – Free Report).

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.